MedPath

Nantes University Hospital

Nantes University Hospital logo
πŸ‡«πŸ‡·France
Ownership
Private
Established
1503-01-01
Employees
10K
Market Cap
-
Website
https://www.chu-nantes.fr

Unruptured Cerebral Aneurysm: Prediction of Evolution

Recruiting
Conditions
Unruptured Intracranial Aneurysm
First Posted Date
2020-10-08
Last Posted Date
2025-05-23
Lead Sponsor
Nantes University Hospital
Target Recruit Count
1000
Registration Number
NCT04578808
Locations
πŸ‡«πŸ‡·

Limoges University Hospital, Limoges, Haute-Vienne, France

πŸ‡«πŸ‡·

Nancy University Hospital, Nancy, Meurthe-et-Moselle, France

πŸ‡«πŸ‡·

Clairval's Hospital, Marseille, Bouches-du-RhΓ΄ne, France

and more 17 locations

Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin Therapy

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Other: Bio-mathematical model
Other: Without bio-mathematical model
First Posted Date
2020-10-01
Last Posted Date
2022-10-21
Lead Sponsor
Nantes University Hospital
Target Recruit Count
37
Registration Number
NCT04572009
Locations
πŸ‡«πŸ‡·

CHU de Nantes, Nantes, France

Predictive Signature of Benralizumab Response

Phase 4
Recruiting
Conditions
Asthma; Eosinophilic
Severe Asthma
Interventions
First Posted Date
2020-09-25
Last Posted Date
2024-04-26
Lead Sponsor
Nantes University Hospital
Target Recruit Count
220
Registration Number
NCT04565483
Locations
πŸ‡«πŸ‡·

CHRU Brest, Brest, France

πŸ‡«πŸ‡·

CHU Lille, Lille, France

πŸ‡«πŸ‡·

CHU Rouen, Rouen, France

and more 17 locations

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma

Phase 2
Recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2020-09-23
Last Posted Date
2024-12-19
Lead Sponsor
Nantes University Hospital
Target Recruit Count
45
Registration Number
NCT04561492
Locations
πŸ‡«πŸ‡·

CHU Bordeaux, Bordeaux, France

πŸ‡«πŸ‡·

CHU Lille, Lille, France

πŸ‡«πŸ‡·

HCL, Lyon, France

and more 2 locations

Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)

Completed
Conditions
Acute Respiratory Distress Syndrome (ARDS)
Cardiac Arrest
Cardiogenic Shock
First Posted Date
2020-09-14
Last Posted Date
2024-01-11
Lead Sponsor
Nantes University Hospital
Target Recruit Count
132
Registration Number
NCT04548739
Locations
πŸ‡«πŸ‡·

AP-HP Necker Hospital, Paris, France

πŸ‡«πŸ‡·

AP-HP Trousseau Hospital, Paris, France

πŸ‡«πŸ‡·

CHU de Nantes, Nantes, France

and more 1 locations

Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)

Phase 1
Completed
Conditions
Acute Myeloid Leukemia (AML)
First Posted Date
2020-09-14
Last Posted Date
2023-04-28
Lead Sponsor
Nantes University Hospital
Target Recruit Count
12
Registration Number
NCT04547062
Locations
πŸ‡«πŸ‡·

CHU of Nantes, Nantes, France

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

Completed
Conditions
Thrombotic Patients
Impact of Treatment With Cytoreducing Agent
Diagnosis of Myeloproliferative Neoplasia
First Posted Date
2020-09-07
Last Posted Date
2025-02-21
Lead Sponsor
Nantes University Hospital
Target Recruit Count
253
Registration Number
NCT04539678
Locations
πŸ‡«πŸ‡·

Nantes University Hospital, Nantes, Loire-Atlantique, France

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

Recruiting
Conditions
Venous Thromboembolism
Atrial Fibrillation
Anticoagulation
Interventions
Diagnostic Test: Estimated anticoagulant level (conversion factor x anti-Xa activity)
First Posted Date
2020-09-04
Last Posted Date
2024-05-07
Lead Sponsor
Nantes University Hospital
Target Recruit Count
2100
Registration Number
NCT04539301
Locations
πŸ‡«πŸ‡·

Nantes University Hospital, Nantes, Loire-Atlantique, France

MICRA - Pilot Study

Not Applicable
Completed
Conditions
Rejection Lung Transplant
Interventions
Procedure: microscopy confocal
First Posted Date
2020-09-03
Last Posted Date
2021-10-06
Lead Sponsor
Nantes University Hospital
Target Recruit Count
20
Registration Number
NCT04536883
Locations
πŸ‡«πŸ‡·

CHU Nantes, Nantes, France

Efficacy of a Multi-faceted Intervention Combining an Educational Outreach Visit to General Practitioners and Patient Education Material to Deprescribe Proton Pump Inhibitors (PPI): a Population-based, Pragmatic, Cluster-randomized Controlled Trial

Not Applicable
Completed
Conditions
Deprescription
Proton Pump Inhibitors
Interventions
Other: GP will receive the educational outreach visit by a DAM (healthcare representative).
Other: Patient education material on PPI deprescribing will be sent to the patients
First Posted Date
2020-08-14
Last Posted Date
2024-04-22
Lead Sponsor
Nantes University Hospital
Target Recruit Count
25000
Registration Number
NCT04513834
Locations
πŸ‡«πŸ‡·

University Hospital, Nantes, France

Β© Copyright 2025. All Rights Reserved by MedPath